Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
NCT06443307
·
clinicaltrials.gov ↗
RECRUITING
Status
933
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Solid Tumor
Interventions
DRUG:
Irinotecan Liposome
Sponsor
Peking University